595 related articles for article (PubMed ID: 6171341)
1. Effects of the L isomer (+)-1,2-bis(3,5-dioxopiperazine-1-yl)propane on cell survival and cell cycle progression of cultured mammalian cells.
Traganos F; Darzynkiewicz Z; Melamed MR
Cancer Res; 1981 Nov; 41(11 Pt 1):4566-76. PubMed ID: 6171341
[TBL] [Abstract][Full Text] [Related]
2. Effects of aclacinomycin on cell survival and cell cycle progression of cultured mammalian cells.
Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
Cancer Res; 1981 Jul; 41(7):2728-37. PubMed ID: 6166368
[TBL] [Abstract][Full Text] [Related]
3. Effects of ellipticine on cell survival and cell cycle progression in cultured mammalian cells.
Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
Cancer Res; 1980 Jul; 40(7):2390-9. PubMed ID: 6155993
[TBL] [Abstract][Full Text] [Related]
4. Action of dihydroxyanthraquinone on cell cycle progression and survival of a variety of cultured mammalian cells.
Traganos F; Evenson DP; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
Cancer Res; 1980 Mar; 40(3):671-81. PubMed ID: 6162553
[TBL] [Abstract][Full Text] [Related]
5. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells.
Traganos F; Ardelt B; Halko N; Bruno S; Darzynkiewicz Z
Cancer Res; 1992 Nov; 52(22):6200-8. PubMed ID: 1330289
[TBL] [Abstract][Full Text] [Related]
6. Effects of a prospective antitumor agent, 1,4-bis(2'-chloroethyl)-1,4-diazabicyclo-[2.2.1] heptane diperchlorate, on cultured mammalian cells.
Traganos F; Darzynkiewicz Z; Bueti C; Melamed MR
Cancer Invest; 1984; 2(1):1-13. PubMed ID: 6584191
[TBL] [Abstract][Full Text] [Related]
7. Effects of prospidine on survival and growth of mammalian cells in culture.
Traganos F; Staiano-Coico L; Darzynkiewicz Z; Melamed MR
J Natl Cancer Inst; 1980 Nov; 65(5):993-9. PubMed ID: 6933266
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of intracellular topoisomerase II by antitumor bis(2,6-dioxopiperazine) derivatives: mode of cell growth inhibition distinct from that of cleavable complex-forming type inhibitors.
Ishida R; Miki T; Narita T; Yui R; Sato M; Utsumi KR; Tanabe K; Andoh T
Cancer Res; 1991 Sep; 51(18):4909-16. PubMed ID: 1654205
[TBL] [Abstract][Full Text] [Related]
9. Lethality, DNA alkylation, and cell cycle effects of adozelesin (U-73975) on rodent and human cells.
Bhuyan BK; Smith KS; Adams EG; Petzold GL; McGovren JP
Cancer Res; 1992 Oct; 52(20):5687-92. PubMed ID: 1394193
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and cellular effects of didemnins A and B.
Crampton SL; Adams EG; Kuentzel SL; Li LH; Badiner G; Bhuyan BK
Cancer Res; 1984 May; 44(5):1796-801. PubMed ID: 6713383
[TBL] [Abstract][Full Text] [Related]
11. Interaction of rhodamine 123 with living cells studied by flow cytometry.
Darzynkiewicz Z; Traganos F; Staiano-Coico L; Kapuscinski J; Melamed MR
Cancer Res; 1982 Mar; 42(3):799-806. PubMed ID: 7059978
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle effects of CC-1065.
Bhuyan BK; Crampton SL; Adams EG
Cancer Res; 1983 Sep; 43(9):4227-32. PubMed ID: 6871861
[TBL] [Abstract][Full Text] [Related]
13. Effect of 7-con-O-methylnogarol on DNA synthesis, survival, and cell cycle progression of Chinese hamster ovary cells.
Adams EG; Crampton SL; Bhuyan BK
Cancer Res; 1981 Dec; 41(12 Pt 1):4981-7. PubMed ID: 6458356
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle progression and chromosome segregation in mammalian cells cultured in the presence of the topoisomerase II inhibitors ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane; ADR-529] and ICRF-159 (Razoxane).
Gorbsky GJ
Cancer Res; 1994 Feb; 54(4):1042-8. PubMed ID: 8313360
[TBL] [Abstract][Full Text] [Related]
15. Effects of new N-alkyl analogues of adriamycin on in vitro survival and cell cycle progression of L1210 cells.
Traganos F; Israel M; Silber R; Seshadri R; Kirschenbaum S; Potmesil M
Cancer Res; 1985 Dec; 45(12 Pt 1):6273-9. PubMed ID: 4063977
[TBL] [Abstract][Full Text] [Related]
16. Proliferation-dependent topoisomerase II content as a determinant of antineoplastic drug action in human, mouse, and Chinese hamster ovary cells.
Sullivan DM; Latham MD; Ross WE
Cancer Res; 1987 Aug; 47(15):3973-9. PubMed ID: 3038304
[TBL] [Abstract][Full Text] [Related]
17. Kinetic analysis of drug-induced G2 block in vitro.
Kimmel M; Traganos F
Cell Tissue Kinet; 1985 Jan; 18(1):91-110. PubMed ID: 3918795
[TBL] [Abstract][Full Text] [Related]
18. Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells.
Sutherland RL; Hall RE; Taylor IW
Cancer Res; 1983 Sep; 43(9):3998-4006. PubMed ID: 6871841
[TBL] [Abstract][Full Text] [Related]
19. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB
Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249
[TBL] [Abstract][Full Text] [Related]
20. Mode of estrogen action on cell proliferation in CAMA-1 cells: II. Sensitivity of G1 phase population.
Leung BS; Potter AH
J Cell Biochem; 1987 Jul; 34(3):213-25. PubMed ID: 3611201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
